Loading... Please wait... Loading... Please wait...
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | revenue | rating |
|---|---|---|---|---|---|---|---|
| Akero Therapeutics, Inc. | $21.44 | $1.59 B | -7.1 | 58 | $0 | ||
| Alnylam Pharmaceuticals, Inc. | $251.07 | $19.33 B | -57.65 | 2100 | $1.83 B | ||
| Apellis Pharmaceuticals, Inc. | $36.26 | $4.90 B | -11.77 | 702 | $396.59 M | ||
| Ascendis Pharma A/S | $135.72 | $7.77 B | -14.19 | 879 | $266.72 M | ||
| BeiGene, Ltd. | $146.81 | $17.07 B | -20.76 | 10000 | $2.46 B | ||
| BioMarin Pharmaceutical Inc. | $81.48 | $15.32 B | 76.12 | 3401 | $2.42 B | ||
| Blueprint Medicines Corporation | $111.64 | $6.47 B | -21.48 | 645 | $249.38 M | ||
| Exelixis, Inc. | $22.09 | $6.37 B | 33.66 | 1310 | $1.83 B | ||
| Halozyme Therapeutics, Inc. | $51.54 | $6.47 B | 21.1 | 373 | $829.25 M | ||
| Legend Biotech Corporation | $46.32 | $8.31 B | -17.66 | 2000 | $285.14 M | ||
| Liquidia Corporation | $12.23 | $1.05 B | -8.77 | 145 | $17.49 M | ||
| Nuvalent, Inc. | $72.79 | $5.11 B | -32.72 | 106 | $0 | ||
| Vaxcyte, Inc. | $77.75 | $7.72 B | -16.54 | 254 | $0 | ||
| Replimune Group, Inc. | $8.09 | $485.18 M | -2.44 | 331 | $0 | ||
| Seagen Inc. | $228.74 | $43.15 B | -57.19 | 3256 | $1.96 B | ||
| Travere Therapeutics, Inc. | $7.90 | $542.80 M | -1.32 | 380 | $145.24 M | ||
| United Therapeutics Corporation | $314.50 | $12.20 B | 13.02 | 1168 | $2.33 B | ||
| Ventyx Biosciences, Inc. | $2.18 | $229.83 M | -1.01 | 74 | $0 |
